All News

A new study at Texas A&M University in College Station investigated the addition of fresh mangoes to traditional therapy for mild to moderate inflammatory bowel disease (IBD).

Coverage from the 2017 meeting of the American Association of Diabetes Educators.

Coverage from the 2017 meeting of the American Association of Diabetes Educators.

Vertex Pharmaceuticals recently announced positive data from phase 1 and 2 studies of 3 triple combination regimens in cystic fibrosis patients with one F508del mutation and one minimal function mutation (F508del/Min). These results are the first to present the potential of treating the underlying cause of those with difficult-to-treat cystic fibrosis.

The idea of quality care for rheumatoid arthritis (RA) often varies among the patient, clinician, and healthcare provider. However, there is a lack of representation of the patient’s perspective involved in the quality indicators that are the current standards for RA outcomes.

The partnership seeks to establish best practices for helping diabetes educators collect data to improve population health. The announcement comes the first day of the annual meeting of the American Association of Diabetes Educators, being held in Indianapolis, Indiana.

Coverage of our peer-reviewed research in the healthcare and mainstream press.

The Healthy Heart Score (HHS) is an effective tool for identifying the risks of atherosclerotic cardiovascular disease (ASCVD) and can assist in determining counseling for primary prevention. A study, recently published by JAMA, evaluated the performance of the lifestyle-based tool, the HHS, which estimates the risk of early ASCVD events in young adults.

There is an association between the use of medication in treating attention deficient/hyperactivity disorder (ADHD) and a lower risk for the development of substance abuse problems in adolescents and adults with ADHD.

There’s a lot happening in clinical practice with immunotherapy treatments: expanded indications for nivolumab and ipilimumab, biomarkers to judge patient response to combinations, and developments with CAR-T.

Corporate wellness programs have gained popularity as employers seek ways to cut healthcare costs. But this is the first study to measure not only health savings, but productivity gains.

This week, the top managed care stories included bipartisan proposals for fixing the Affordable Care Act (ACA); FDA approved a targeted therapy for patients with acute myeloid leukemia who have a rare genetic mutation; and a study found that more patients have gained access to clinical trials after the ACA was implemented.

The number of individuals from Indiana in the Trump administration has increased: Jerome M. Adams, MD, the former Indiana health commissioner was confirmed by the Senate as the new surgeon general. Adams replaces Vivek Murthy, MD, who was pushed out by the Trump administration in April.

A rule that would have created national standards for menu labels was halted a day before it took effect in May. Advocates for healthy eating cried foul, but a trade group for convenience stores said the rule would have harmed its members.

Provider roles in team-based care in oncology need clarity, and now, results from a new study affirm the confusion experience by patients treated for breast cancer on who should lead their care posttreatment.

More than 100 million adults don't have dental coverage, which is not an essential health benefit even though data show rising numbers of emergency department cases related to dental problems. A Michigan experiment shows a possible solution, but even the study's author said it is not a panacea.

The Institute for Clinical and Economic Review is seeking public comments on its recently released outline of proposed adaptations involving the assessment of certain treatments for ultra-rare conditions, also known as orphan drugs.

Evidence shows aiding patients' spiritual needs improves their health, but few doctors address them.

There is an association between computed tomography (CT) detectable structural changes in the lungs of patients with chronic obstructive pulmonary disease (COPD) and changes in bacterial communities that influence alterations in the relationship between microbes and host cells, according to a new study published in PLOS One.

The approval follows a review of phase 2 results from CheckMate-142.

The new immunotherapy of chimeric antigen receptor (CAR)-T cells has demonstrated the ability to increase clinical remission in multiple myeloma patients by targeting the B-cell maturation protein that participates in disease progression.

A recent study described why physicians find that deprescribing a patient's ongoing medication may be easier said than done.

The reduced mortality risk was not seen in patients who did not have diabetes before surgery. But in those who did, the results were dramatic.

Enasidenib (Idhifa), developed by Celgene and Agios, has been granted FDA approval in tandem with a companion diagnostic test to detect IDH-2 mutations.

In an effort to brainstorm strategies that will boost patient engagement in medical device development, the FDA has announced it will host the first meeting of its Patient Engagement Advisory Committee this fall.

In the days since Senator John McCain (R-Arizona) turned down his thumb and became the third Republican to vote against the “skinny repealâ€

After Senator John McCain (R-Arizona) returned to Congress last week after surgery and a brain tumor diagnosis, he called on his fellow senators to put aside partisan differences and work together on healthcare reform. In the House of Representatives, a bipartisan group is trying to do just that.